Clofarabine-induced Capillary Leak Syndrome in a Child With Refractory Acute Lymphoblastic Leukemia

---

Copy For Citation

Baytan B., Ozdemir O., Gunes A. M., DÖNMEZ O.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, vol.32, no.2, pp.144-146, 2010 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 32 Issue: 2
• Publication Date: 2010
• Doi Number: 10.1097/mph.0b013e3181bf298b
• Journal Name: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.144-146
• Bursa Uludag University Affiliated: Yes

Abstract

Clofarabine has significant efficiency in children with relapsed or refractory leukemia. In previous pediatric trials, various adverse effects have been described. In this case, we report a child with refractory acute lymphoblastic leukemia who developed fatal capillary leak syndrome during clofarabine therapy.